General Information of the Protein
| Protein ID |
PT05455
|
||||
|---|---|---|---|---|---|
| Protein Name |
Transforming growth factor beta-1 proprotein
|
||||
| Gene Name |
TGFB1
|
||||
| Secondarily Gene Name |
TGFB
|
||||
| Sequence |
MPPSGLRLLPLLLPLLWLLVLTPGRPAAGLSTCKTIDMELVKRKRIEAIRGQILSKLRLASPPSQGEVPPGPLPEAVLALYNSTRDRVAGESAEPEPEPEADYYAKEVTRVLMVETHNEIYDKFKQSTHSIYMFFNTSELREAVPEPVLLSRAELRLLRLKLKVEQHVELYQKYSNNSWRYLSNRLLAPSDSPEWLSFDVTGVVRQWLSRGGEIEGFRLSAHCSCDSRDNTLQVDINGFTTGRRGDLATIHGMNRPFLLLMATPLERAQHLQSSRHRRALDTNYCFSSTEKNCCVRQLYIDFRKDLGWKWIHEPKGYHANFCLGPCPYIWSLDTQYSKVLALYNQHNPGASAAPCCVPQALEPLPIVYYVGRKPKVEQLSNMIVRSCKCS
Show/Hide
|
||||
| Organism |
Homo sapiens, Human
|
||||
| Protein Classification |
Secreted protein
|
||||
| Function |
Transforming growth factor beta-1 proprotein: Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-1 (TGF-beta-1) chains, which constitute the regulatory and active subunit of TGF-beta-1, respectively.
Show/Hide
|
||||
| Uniprot ID |
Show/Hide
|
||||
| Ensembl ID | |||||
| HGNC ID | |||||
| Subcellular Location |
Secreted
Extracellular space
Extracellular matrix
|
||||
Clinical Information about the Protein
Target 1 ( Transforming growth factor beta 1 (TGFB1) )
| Target Type | Successful Target | ||||
|---|---|---|---|---|---|
| Disease | 2 Target-related Diseases | 2 | |||
| 1 | Idiopathic pulmonary fibrosis [ICD-11: CB03.4] | ||||
| 2 | Arteriosclerosis [ICD-11: BD40] | ||||
| Approved Drug(s) | 1 Approved Drug | 1 | |||
| 1 | Pirfenidone | Approved | |||
| Clinical Trial Drug(s) | 1 Clinical Trial Drug | 1 | |||
| 1 | LY2157299 | Phase 2/3 | |||
Target 2 ( TGFB1 messenger RNA (TGFB1 mRNA) )
| Target Type | Literature-reported Target | ||||
|---|---|---|---|---|---|